www.engrail.comHealthcare / BioTech & PharmaFounded: 2019Funding to Date: $221MM
Engrail Therapeutics is a pharmaceutical company focused on developing precision-targeted therapies striving to transform the lives of patients suffering from severe and life-limiting neurological, neuropsychiatric, and neurodevelopmental disorders. The company is seeking to leverage scientific insights into molecular mechanisms and neurocircuitry with the goal of advancing the development of novel treatments aimed at addressing unmet medical needs. Engrail Therapeutics was founded by Stephen Cunningham and Vikram Sudarsan in 2019 and is headquartered in San Diego, CA.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Engrail Therapeutics.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.